BHVN 241220 45.00P (BHVN241220P45000) Stock Options, News & Quotes

US OptionsDetailed Quotes

BHVN241220P45000

Watchlist

5.50
+0.10+1.85%

15min DelayClose Nov 22 16:00 ET

5.50High5.00Low

Intraday

5D
Daily

News

Morgan Stanley Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $69
Moomoo NewsNov 15 08:31 ET · Ratings
Biohaven Ltd. (BHVN) Receives a Buy From Morgan Stanley
TipRanksNov 15 08:16 ET · Ratings
A Quick Look at Today's Ratings for Biohaven(BHVN.US), With a Forecast Between $59 to $76
Moomoo NewsNov 14 08:00 ET · Ratings
Biohaven Is Maintained at Outperform by RBC Capital
Dow JonesNov 13 09:59 ET · Ratings
RBC Capital Maintains Biohaven(BHVN.US) With Buy Rating, Cuts Target Price to $66
Moomoo NewsNov 13 07:31 ET · Ratings
BTIG Maintains Biohaven(BHVN.US) With Buy Rating, Maintains Target Price $59
Moomoo NewsNov 13 06:36 ET · Ratings

Comments

Stock_Drift

Sep 23 17:03

$Biohaven (BHVN.US)$

Jaguar8

Sep 23 06:54

NEWS

$Biohaven (BHVN.US)$
Biohaven Achieves Positive Topline Results in Pivotal Study of Troriluzole in Spinocerebellar Ataxia (SCA)
• Troriluzole 200 mg dosed orally, once daily, in patients with SCA met the study's primary endpoint on the change from baseline in the modified functional Scale for the Assessment and Rating of Ataxia (f-SARA) at 3 years in all study population genotypes.
◦ Troriluzole also showed statistically significant superiority after both 1 and 2 years of treatment.
• Tror...

Stock_Drift

Sep 22 07:57

$Biohaven (BHVN.US)$

Mr Long Term

Jul 24 18:48

Columns Top Calls on Wall Street | Nvidia, Tesla, Spotify, Apple, GM, Alphabet & More.

Here are Wednesday’s biggest calls on Wall Street:
RBC upgrades Estee Lauder $Estee Lauder (EL.US)$ to outperform from sector perform
RBC said it sees an attractive risk/reward.
“We are upgrading EL shares to Outperform. At this point, we believe EPS and investor sentiment have troughed and believe the risk-to-reward profile skews favorable.”
Morgan Stanley reiterates Tesla $Tesla (TSLA.US)$ as overweight
Morgan Sta...

Meltyy

May 16 01:29

🔔 Perceptive Advisors Q1 ‘24* Holdings Released... 🐳

» Holdings: 112
» Holdings in Top 20: 58.46%
» Qtr over Qtr Change**: 28.47%
Top Holdings:
$Cerevel Therapeutics Holdings (CERE.US)$
$Amicus Therapeutics (FOLD.US)$
$Iovance Biotherapeutics (IOVA.US)$
$Arcellx (ACLX.US)$
$Nuvalent (NUVL.US)$
$Apogee Therapeutics (APGE.US)$
$Inhibrx (INBX.US)$
$Fusion Pharmaceuticals (FUSN.US)$
$Rhythm Pharmaceuticals (RYTM.US)$
$Vaxcyte (PCVX.US)$
$Soleno Therapeutics (SLNO.US)$
$Medtronic (MDT.US)$
$Madrigal Pharmaceuticals (MDGL.US)$
...